Coverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 27, 2026. Only the current version of each report is used.
54,415 report citations, newest first.
NO SURPRISE BILL, LLC · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$30,000
Paid to lobbying firm
CitesH.R. 4710· this member:Cosponsored
Issues related to funding for Medicaid and Medicare. Issues related to the No Surprises Act Enforcement Act (H.R.4710/S.2420).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VISA, INC. · lobbying firm or registrant: 535 GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Financial Institutions/Investments/Securities
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
H.R. 3633, Digital Asset Market Clarity Act of 2025 H.R. 7035 and S. 3623 CCCA
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF ADOPTION AND ASSISTED REPRODUCTION ATTORNEYS (FKA AM AC ADPT ATTNYS) · lobbying firm or registrant: SIMS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$20,000
Paid to lobbying firm
CitesH.R. 1· this member:Recorded votes on 3 roll calls
S. 1458/H.R. 2833, the Adoption Tax Credit Refundability Act of 2025. Implementation of Adoption Tax Credit provision in Sec. 70402 of H.R. 1 (P.L. 119-21).
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF ADOPTION AND ASSISTED REPRODUCTION ATTORNEYS (FKA AM AC ADPT ATTNYS) · lobbying firm or registrant: SIMS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Family issues/Abortion/Adoption
$20,000
Paid to lobbying firm
CitesH.R. 7040· this member:Cosponsored
…ternational adoption. Issues related to IVF access. S. 3285/H.R. 6170, the ADOPT Act of 2025. Issues related to foster care, adoption, and citizenship. S. 3101/H.R. 7040, the Stopping Adversarial Foreign Exploitation of Kids In Domestic Surrogacy Act. Issues related to surrogacy in Executive Order 14419, Ending Birth Tourism (9…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Energy/Nuclear
$50,000
Paid to lobbying firm
CitesH.R. 1047· this member:CosponsoredRecorded vote on 1 roll call
…on language in Section 9. The Promoting Cross-Border Energy Infrastructure Act (H.R. 3062) The Grid Reliability and Infrastructure Deployment (GRID) Power Act (H.R. 1047) The National Coal Council Reestablishment Act (H.R. 3015) Feedback on data center construction, development and power needs. Federal Permitting Reform: Suppor…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Energy/Nuclear
$50,000
Paid to lobbying firm
CitesH.R. 3015· this member:Recorded vote on 1 roll call
…y Infrastructure Act (H.R. 3062) The Grid Reliability and Infrastructure Deployment (GRID) Power Act (H.R. 1047) The National Coal Council Reestablishment Act (H.R. 3015) Feedback on data center construction, development and power needs. Federal Permitting Reform: Support for the Standardizing Permitting and Expediting Economic…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Energy/Nuclear
$50,000
Paid to lobbying firm
CitesH.R. 3062· this member:CosponsoredRecorded vote on 1 roll call
…ce Committee's Pipeline Safety Authorization Act (H.R. 9338) and damage prevention language in Section 9. The Promoting Cross-Border Energy Infrastructure Act (H.R. 3062) The Grid Reliability and Infrastructure Deployment (GRID) Power Act (H.R. 1047) The National Coal Council Reestablishment Act (H.R. 3015) Feedback on data cen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Energy/Nuclear
$50,000
Paid to lobbying firm
CitesH.R. 3898· this member:Recorded votes on 2 roll calls
…editing Economic Development Act (SPEED Act) (H.R. 4776) Support for provisions of the Promoting Efficient Review for Modern Infrastructure for Today (PERMIT) (H.R. 3898) Support for the Studying NEPAs Impact on Projects Act (H.R. 573), which requires the Council on Environmental Quality (CEQ) to publish an annual report on NEP…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Energy/Nuclear
$50,000
Paid to lobbying firm
CitesH.R. 4776· this member:Recorded votes on 5 roll calls
…truction, development and power needs. Federal Permitting Reform: Support for the Standardizing Permitting and Expediting Economic Development Act (SPEED Act) (H.R. 4776) Support for provisions of the Promoting Efficient Review for Modern Infrastructure for Today (PERMIT) (H.R. 3898) Support for the Studying NEPAs Impact on Pro…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Telecommunications
$50,000
Paid to lobbying firm
CitesH.R. 3898· this member:Recorded votes on 2 roll calls
…editing Economic Development Act (SPEED Act) (H.R. 4776) Support for provisions of the Promoting Efficient Review for Modern Infrastructure for Today (PERMIT) (H.R. 3898) Support for the Studying NEPAs Impact on Projects Act (H.R. 573), which requires the Council on Environmental Quality (CEQ) to publish an annual report on NEP…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Telecommunications
$50,000
Paid to lobbying firm
CitesH.R. 4776· this member:Recorded votes on 5 roll calls
…fiber broadband funding and programs, in general. Permit Reform: Support for the Standardizing Permitting and Expediting Economic Development Act (SPEED Act) (H.R. 4776) Support for provisions of the Promoting Efficient Review for Modern Infrastructure for Today (PERMIT) (H.R. 3898) Support for the Studying NEPAs Impact on Pro…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$50,000
Paid to lobbying firm
CitesH.R. 2126· this member:Cosponsored
Support for the Fair and Open Competition Act (H.R.2126/S.1064). Support for repeal of President Biden EO 14063 and related FAR rule. Opposition to project labor agreement mandates/preferences in Inflation Reduction…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Immigration
$50,000
Paid to lobbying firm
CitesH.R. 4393· this member:Cosponsored
The Dignity Act (H.R. 4393) Essential Workers for Economic Advancement Act (H.R. 3734) Engagement on VISA, DACA, TPS, and other legal immigration programs salient to construction industr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Government Issues
$50,000
Paid to lobbying firm
CitesH.R. 425· this member:Cosponsored
Support for the Prove it Act of 2025 (H.R. 425/S. 100). Education about and comments regarding OMB Proposed Rule, Regulation for Federal Financial Assistance (91 FR 32198, Docket No. OMB-2026-0034)
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Copyright/Patent/Trademark
$2,560,000
Spent on own lobbying
CitesH.R. 8413· this member:Cosponsored
…lity of AI Assisted Inventions Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act Compulsory Licensing ---28 U.S.C. 1498 - Patent and copyright cases Data Privacy ---H.R.8413: SECURE Data Act ---Implementation of BIOSECURE Act Drug Patenting ---H.R.3160/S.1553: PREVAIL Act ---H.R.3269/S.2276: Eliminating Thickets to Increase Competi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesH.R. 1672· this member:Cosponsored
…Act ---S.1954: Biosimilar Red Tape Elimination Act ---Biosimilars Competition (General) ---Interchangeability and Pharmacy Substitution Cell & Gene Therapy ---H.R.1672: Maintaining Investments in New Innovation (MINI) Act Clinical Trial Data in China ---Next-Generation U.S. Clinical Development to Accelerate Cures - Legislati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesH.R. 5509· this member:Cosponsored
…-H.R.10359: Priority for Pediatric Cures Act ---S.822: Scientific EXPERT Act ---Rare Disease Pilot Program Reimbursement and Coverage of Innovative Products ---H.R.5509/S.2903:SAFE STEP Act ---S.864/H.R.6423: HELP Copays Act ---Access to Innovative Treatments ---CMMI Authority ---Implementation of the Inflation Reduction Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesH.R. 8413· this member:Cosponsored
…ovation (MINI) Act Clinical Trial Data in China ---Next-Generation U.S. Clinical Development to Accelerate Cures - Legislative Discussion Draft Data Privacy ---H.R.8413: SECURE Data Act ---Clinical Trial Data in China ---Implementation of BIOSECURE Act Diagnostics and Personalized Medicine Regulation and Oversight Diversity &…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
…sign ---Most Favored Nation Drug Pricing Proposals ---Pricing and Rebates National Defense ---Medical Countermeasure Priority Review Voucher Reauthorization ---H.R.8800: National Defense Authorization Act for Fiscal Year 2027 National Security ---H.R.10568: Protecting Biological Data as Critical Infrastructure Act ---H.R.10569…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesH.R. 9599· this member:Cosponsored
…us Diseases ---Vaccine Injury Compensation Program 340B Drug Discount Program ---H.R.5256: 340B ACCESS Act ---H.R.9504: Tax Exempt Hospital Transparency Act ---H.R.9599: SECURE 340B Act ---S.5244: SUSTAIN 340B Act ---Program Implementation & Oversight ---Rebate Models Accelerated Approval Artificial Intelligence (AI) Alternati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Homeland Security
$2,560,000
Spent on own lobbying
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
…rug User Fee Act (PDUFA) VIII Implementation ---VICP/CICP Biodefense Research, Development and Procurement Issues ---H.R.1980: State Strategic Stockpile Act ---H.R.8800: National Defense Authorization Act for Fiscal Year 2027 ---Ebola BDBV Outbreak ---Hanta Virus ---Medical Countermeasure Priority Review Voucher Reauthorizatio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesH.R. 1672· this member:Cosponsored
…Biosimilars Access and Affordability Act ---S.1954: Biosimilars Red Tape Elimination Act ---Interchangeability and Pharmacy Substitution Cell & Gene Therapy ---H.R.1672: Maintaining Investments and New Innovation (MINI) Act ---H.R.7871/S.1637: MVP Act Clinical Trial Data in China Data Privacy ---H.R.8413: SECURE Data Act Diver…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesH.R. 7871· this member:Cosponsored
…Tape Elimination Act ---Interchangeability and Pharmacy Substitution Cell & Gene Therapy ---H.R.1672: Maintaining Investments and New Innovation (MINI) Act ---H.R.7871/S.1637: MVP Act Clinical Trial Data in China Data Privacy ---H.R.8413: SECURE Data Act Diversity & Inclusion ---Decentralized Clinical Trials Drug Evaluation a…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesH.R. 8413· this member:Cosponsored
…Cell & Gene Therapy ---H.R.1672: Maintaining Investments and New Innovation (MINI) Act ---H.R.7871/S.1637: MVP Act Clinical Trial Data in China Data Privacy ---H.R.8413: SECURE Data Act Diversity & Inclusion ---Decentralized Clinical Trials Drug Evaluation and Review ---FDA Hiring Flexibility Drug Importation Drug Manufacturin…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesH.R. 946· this member:Cosponsored
…osimilars Act ---S.1097: Interagency Patent Coordination and Improvement Act ---Patent Thickets ---Restrictions on Intellectual Property Rights Drug Pricing ---H.R.946: ORPHAN Cures Act ---H.R.1492/S.832: Ensuring Pathways to Innovative Cures (EPIC) Act ---H.R.1672: Maintaining Investments and New Innovation (MINI) Act ---H.R…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
